SHG · Clinical Research Centre/Lung Cancer CDR (Pilot)
CR
Pilot environment — synthetic demographics; real de-identified pathology sample (n=62; +80 synthetic; total 142).
All patients
Patient Record · MRN SMC-197163

SYN-017

[SYN] Mike Aurora · 71y · Female · Indian · BMI 20.1 · ECOG 1
SMCAS - Sunway Medical Centre AS · Medical Oncology · Dr. Kavitha Sundaram
IIIB (T3, N2)Disease-free
ALK fusion
Clinical storyline

[SYN] Mike Aurora, a 71-year-old Indian female (never, ECOG 1), presented in 2024-07 with hemoptysis (blood-streaked sputum). Workup confirmed Adenocarcinoma (Stage III, ALK fusion). The MDT recommended first-line alectinib. Current status: Disease-free.

HPE Results
Adenocarcinoma: Acinar, ALK rearranged
Clinical Stage
IIIB (T3, N2)
Pathological Stage
IIIB (T3, N2, M0)
Adenocarcinoma Subtype
Acinar
CEA (ng/mL)
12.6
Tumor (CT/PET)
3.8 cm
PET SUV
6.55
NGS Results
ALK fusion positive (EML4-ALK)